These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3035744)

  • 1. [2.5 mg versus 5 mg neostigmine for reversal of pancuronium bromide].
    Heier T; Steen PA
    Tidsskr Nor Laegeforen; 1987 Mar; 107(9):849-50. PubMed ID: 3035744
    [No Abstract]   [Full Text] [Related]  

  • 2. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
    Donati F; Ferguson A; Bevan DR
    Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of d-tubocurarine- and pancuronium-induced neuromuscular blockades by pyridostigmine in man.
    Fogdall RP; Miller RD
    Anesthesiology; 1973 Nov; 39(5):504-9. PubMed ID: 4355635
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of neuromuscular blockade--effects of administration of atropine and neostigmine at different rates in man.
    el Hakim M
    Anaesthesiol Reanim; 1987; 12(5):299-303. PubMed ID: 3675813
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical study of pancuronium as muscle relaxant in anesthesia.
    Park WY; Macnamara TE
    Anesth Analg; 1973; 52(4):502-7. PubMed ID: 4123904
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies on the reversal of the neuromuscular blockade produced by pancuronium bromide. I. The effects of glycopyrrolate and pyridostigmine.
    Gyermek L
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):377-86. PubMed ID: 810297
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antagonism to neuromuscular effect of subcutaneous administration of pancuronium by neostigmine].
    Iwasaki H; Igarashi M; Omori H; Omote K; Namiki A
    Masui; 1994 Jun; 43(6):885-8. PubMed ID: 8072147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery from pancuronium. A comparison between old and young patients.
    Marsh RH; Chmielewski AT; Goat VA
    Anaesthesia; 1980 Dec; 35(12):1193-6. PubMed ID: 6257134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of pancuronium in renal failure: no recurarization.
    Bevan DR; Archer D; Donati F; Ferguson A; Higgs BD
    Br J Anaesth; 1982 Jan; 54(1):63-8. PubMed ID: 6275872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neostigmine antagonism of succinylcholine phase II block: a comparison with pancuronium.
    Futter ME; Donati F; Sadikot AS; Bevan DR
    Can Anaesth Soc J; 1983 Nov; 30(6):575-80. PubMed ID: 6315193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of gallamine and pancuronium with tubocurarine under morphine-nitrous oxide-oxygen anesthesia in man.
    Park WY; Balingit PE; Macnamara TE
    Anesth Analg; 1974; 53(5):723-9. PubMed ID: 4472154
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental and clinical study of the effects of pancuronium bromide, a neuromuscular blocking agent.
    Manani G; Galzigna L; Mammano S; Gasparetto A
    Arzneimittelforschung; 1972 Sep; 22(9):1528-34. PubMed ID: 4264758
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical studies involving neostigmine reversal of d-tubocurarine, gallamine, and pancuronium in man.
    De Angelis J
    Anesth Analg; 1974; 53(2):268-70. PubMed ID: 4856137
    [No Abstract]   [Full Text] [Related]  

  • 14. Atropine-neostigmine mixture: a dose-response study.
    Naguib M; Gomaa M
    Can J Anaesth; 1989 Jul; 36(4):412-7. PubMed ID: 2758540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil potentiation of neuromuscular blockade: failure of reversal with neostigmine but prompt reversal with edrophonium.
    Jones RM; Cashman JN; Casson WR; Broadbent MP
    Anesth Analg; 1985 Oct; 64(10):1021-5. PubMed ID: 4041146
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of verapamil with gallamine and pancuronium and reversal of combined neuromuscular blockade with neostigmine and edrophonium.
    Wali FA
    Eur J Anaesthesiol; 1986 Sep; 3(5):385-93. PubMed ID: 3780695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of pancuronium and tubocurarine blocks by edrophonium or neostigmine: a comparative study.
    Mirakhur RK
    Eur J Anaesthesiol; 1987 Nov; 4(6):411-9. PubMed ID: 3446491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical evaluation of pyridostigmine bromide in the reversal of pancuronium.
    Lippmann M; Rogoff RC
    Anesth Analg; 1974; 53(1):20-3. PubMed ID: 4855709
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal of pancuronium with edrophonium.
    Bevan DR
    Anaesthesia; 1979; 34(7):614-9. PubMed ID: 229740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery from pancuronium blockade in the neonatal intensive care unit.
    Goudsouzian NG; Crone RK; Todres ID
    Br J Anaesth; 1981 Dec; 53(12):1303-9. PubMed ID: 6274373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.